An exploratory study on the checkout rate of circulating tumor cells and the prediction of efficacy of neoadjuvant therapy and prognosis in patients with HER-2-positive early breast cancer

BACKGROUND: Neoadjuvant therapy is a standard treatment for patients with large, nonmetastatic breast cancer and may allow breast-conserving surgery after tumor downsizing while decreasing the risk of subsequent relapse. Dynamic changes of circulation tumor cells (CTCs) have a role in predicting tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jinmei, Wu, Jiangling, Hao, Xiaopeng, Li, Ping, Zhang, Huiqiang, Wu, Xuexue, Chen, Jiaxin, Liu, Jiawei, Xiao, Jinyi, Zhang, Shaohua, Jiang, Zefei, Yang, Yanlian, Hu, Zhiyuan, Wang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388052/
https://www.ncbi.nlm.nih.gov/pubmed/35992876
http://dx.doi.org/10.3389/fonc.2022.966624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9388052/
https://www.ncbi.nlm.nih.gov/pubmed/35992876
http://dx.doi.org/10.3389/fonc.2022.966624

Ejemplares similares